Epsiprantel is a chemical compound primarily used as an anthelmintic agent, particularly effective against certain parasitic infections in veterinary medicine. It belongs to the class of compounds known as praziquantel derivatives, which are characterized by their ability to disrupt the integrity of the parasite's cell membranes, leading to paralysis and death of the organism. Epsiprantel is typically administered orally and is known for its relatively low toxicity to mammals, making it a safer option for treating infections in animals. The compound is soluble in organic solvents but has limited solubility in water, which influences its formulation and delivery methods. Its mechanism of action involves the alteration of calcium ion permeability in the parasite, resulting in muscle contraction and subsequent paralysis. Epsiprantel is often used in combination with other antiparasitic agents to enhance efficacy and broaden the spectrum of activity against various helminths. As with any pharmaceutical, proper dosage and administration are crucial to ensure effectiveness while minimizing potential side effects.

Epsiprantel

98123-83-2:  Epsiprantel, BRL 38705,  (+-)-2-(Cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino(2,1-a)(2)benzazepin-4(1H)-one,  Epsiprantelum, Pyrazino[2,1-a][2]benzazepin-4(1H)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro-,  Epsiprantelum [Latin], Epsiprantel [INN:BAN],  BRL 38705, 2-(Cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino[2,1-a][2]benzazepin-4(1H)-one, Epsiprantel,  UNII-0C1SPQ0FSR,  Cestex

Epsiprantel is a drug that belongs to the group of anthelmintic drugs. It is given orally, and is used to treat roundworms, tapeworms, and flukes in animals. Epsiprantel has been shown to have an effect on the polymerase chain reaction (PCR) for endoparasites in rats. This drug also has a significant effect on the active substances of these parasites. Epsiprantel is not effective against adult worms, but it can be used as a prophylactic treatment for young animals. Epsiprantel binds to a carbonyl group on the parasite's outer surface, which causes paralysis and death of the parasite by interfering with its water-surface breathing mechanism. The active substance may be excreted in the urine or feces within six hours after administration.

Epsiprantel is an antiparasitic for canine worms.

CAS 98123-83-2: Epsiprantel

Epsiprantel

Ref: 3D-FE180300

Epsiprantel

Ref: TM-T27278

Pyrazino[2,1-a][2]benzazepin-4(1H)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro-

Ref: IN-DA0015I2